INDACATEROL/MOMETASONE dry powder inhaler (Atectura Breezhaler®)

Clinical Indication

Maintenance treatment of asthma in adults and adolescents 12 years of age and older


Not yet reviewed

Date of classification

May 2021


Not yet reviewed drugs with no traffic light recommendation so not yet approved for use in LLR.

  • New medicines, devices, appliances.
  • New indication of existing medicine.
  • New NICE TA which has not been reviewed.
  • Not been requested for review by either TAS/LPT MMC.